Case Report: A leadless and endovascular pacemaker teamwork.

atrioventricular synchrony device infection endovascular pacemaker lead dysfunction leadless pacemaker

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 01 09 2023
accepted: 11 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

Cardiac Implantable Electronic Device infections increase short- and long-term mortality, along with healthcare costs. Leadless pacemakers (PM) were developed to overcome pocket- and minimize lead-related complications in selected high-risk patients. Recent advancements enable leadless devices to mechanically detect atrial activity, facilitating atrioventricular (AV) synchronous stimulation. A 90-year-old woman, implanted with a dual-chamber pacemaker eight years ago due to sinus node dysfunction, presented with syncope. A diagnosis of complete AV block, in the setting of ventricular lead dysfunction was made. Due to a high risk of infection, the patient was implanted with a leadless PM capable of maintaining AV synchrony in VDD mode (MICRA™ model MC1AVR1). The transvenous PM was programmed to AAI-R mode to drive the atria, which, in turn, triggered the leadless PM to stimulate the ventricles. At six month follow-up, the AV synchrony rate was 85%. The combination of classic atrial pacing with leadless ventricular stimulation can be used in high-risk patients to reduce the risk of complications, in the setting of ventricular lead dysfunction. In this manner, AV synchrony can be maintained, improving hemodynamic parameters and quality of life. Low sinus rate variability at rest is essential to achieve a high AV synchrony rate in such cases.

Sections du résumé

Background UNASSIGNED
Cardiac Implantable Electronic Device infections increase short- and long-term mortality, along with healthcare costs. Leadless pacemakers (PM) were developed to overcome pocket- and minimize lead-related complications in selected high-risk patients. Recent advancements enable leadless devices to mechanically detect atrial activity, facilitating atrioventricular (AV) synchronous stimulation.
Case summary UNASSIGNED
A 90-year-old woman, implanted with a dual-chamber pacemaker eight years ago due to sinus node dysfunction, presented with syncope. A diagnosis of complete AV block, in the setting of ventricular lead dysfunction was made. Due to a high risk of infection, the patient was implanted with a leadless PM capable of maintaining AV synchrony in VDD mode (MICRA™ model MC1AVR1). The transvenous PM was programmed to AAI-R mode to drive the atria, which, in turn, triggered the leadless PM to stimulate the ventricles. At six month follow-up, the AV synchrony rate was 85%.
Conclusion UNASSIGNED
The combination of classic atrial pacing with leadless ventricular stimulation can be used in high-risk patients to reduce the risk of complications, in the setting of ventricular lead dysfunction. In this manner, AV synchrony can be maintained, improving hemodynamic parameters and quality of life. Low sinus rate variability at rest is essential to achieve a high AV synchrony rate in such cases.

Identifiants

pubmed: 38028465
doi: 10.3389/fcvm.2023.1287506
pmc: PMC10666049
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1287506

Informations de copyright

© 2023 Zeriouh, Sousonis, Menè, Boveda, Voglimacci-Stephanopoli and Combes.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Heart Rhythm. 2020 Dec;17(12):2037-2045
pubmed: 32717315
JACC Clin Electrophysiol. 2020 Jan;6(1):94-106
pubmed: 31709982
Europace. 2022 Oct 13;24(10):1691-1708
pubmed: 35912932
N Engl J Med. 1998 Apr 16;338(16):1097-104
pubmed: 9545357
Arch Intern Med. 2011 Nov 14;171(20):1821-8
pubmed: 21911623
Circulation. 1998 Mar 17;97(10):987-95
pubmed: 9529267
Heart Rhythm. 2018 Sep;15(9):1363-1371
pubmed: 29758405
Heart Rhythm. 2020 Aug;17(8):1393-1397
pubmed: 32247833
Circulation. 2010 Oct 19;122(16):1553-61
pubmed: 20921437
Europace. 2018 Dec 1;20(12):1974-1980
pubmed: 29672690
Circulation. 2004 Feb 3;109(4):443-51
pubmed: 14757681
Pacing Clin Electrophysiol. 2006 Feb;29(2):142-5
pubmed: 16492298
Eur Heart J. 2015 Nov 21;36(44):3075-3128
pubmed: 26320109
Circulation. 2007 Sep 18;116(12):1349-55
pubmed: 17724263

Auteurs

Sarah Zeriouh (S)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Vasileios Sousonis (V)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Roberto Menè (R)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Serge Boveda (S)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Quentin Voglimacci-Stephanopoli (Q)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Stéphane Combes (S)

Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.

Classifications MeSH